Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern

BACKGROUND: The role of humoral immunity in COVID-19 is not fully understood, owing, in large part, to the complexity of antibodies produced in response to the SARS-CoV-2 infection. There is a pressing need for serology tests to assess patient-specific antibody response and predict clinical outcome....

Descripción completa

Detalles Bibliográficos
Autores principales: Voss, Courtney, Esmail, Sally, Liu, Xuguang, Knauer, Michael J., Ackloo, Suzanne, Kaneko, Tomonori, Lowes, Lori, Stogios, Peter, Seitova, Almagul, Hutchinson, Ashley, Yusifov, Farhad, Skarina, Tatiana, Evdokimova, Elena, Loppnau, Peter, Ghiabi, Pegah, Haijan, Taraneh, Zhong, Shanshan, Abdoh, Husam, Hedley, Benjamin D., Bhayana, Vipin, Martin, Claudio M., Slessarev, Marat, Chin-Yee, Benjamin, Fraser, Douglas D., Chin-Yee, Ian, Li, Shawn S.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410046/
https://www.ncbi.nlm.nih.gov/pubmed/34081630
http://dx.doi.org/10.1172/jci.insight.148855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410046/
https://www.ncbi.nlm.nih.gov/pubmed/34081630
http://dx.doi.org/10.1172/jci.insight.148855

Ejemplares similares